Isomab

Developer of antibodies against vascular diseases

placeNottingham, England, United Kingdom calendar_todayFounded 2022 groups3 employees language isomab.bio

Registered entities

Social engagement

Social engagement: 1.1K social following, 9 posts in the last 12 months — below the industry typical range.

Investor mix

5 investors on record; lead investors include Broadview Ventures, Midlands Engine Investment Fund, Mercia, SCVC.

Investor typeCountShare
Venture capital360%
Private equity120%
Other / undisclosed120%

Recent activity

5 Jun 2026
Event
CWOW Venture Tour
21 May 2026
Leadership hire
VP of Translational
15 May 2026
Event
BII Therapeutics Vertical Summit 2026
Coming soon